Download - ISBTOC
-
8/22/2019 ISBTOC
1/5
1
An Overview of the Life Sciences
and Outsourcing Landscape in India:
Spotlight on Bangalore
A CanBiotech Report
CanBiotech, 2007
-
8/22/2019 ISBTOC
2/5
2
Executive Summary:
Countries that can offer lower costs during research and development
while ensuring adequate protection of intellectual property and adherenceto global regulatory standards are well positioned to attract the attention of
large biopharmaceutical companies looking to outsource drug discovery
and/or development.
India is poised to make big contributions to the global healthcare industry.
The country is emerging as a competitive base for several segments of the
R&D value chain, especially in late discovery, preclinical, and clinicaldevelopment.
Major multinationals have established subsidiaries in India. U.S. andEuropean companies are collaborating with Indian firms to develop new
drugs and vaccines, to conduct clinical trials and toxicity studies, to
perform molecular modeling and lead optimization, to provide computer
services such as bioinformatics, and to develop industrial production
processes for new drug ingredients. Similarly, venture capitalists from theU.S. and Singapore are helping to fund start-up biotechnology companies
in India.
Indian companies are also set to tap into the global biopharmaceutical
outsourcing market. These companies are increasingly moving into thedeveloped market and transitioning from bulk drugs to formulation
exports. Indian companies are also expected to produce many of the top
drop drugs that are scheduled to lose patent protection over the next fewyears. India will not only be accessing the generics market, but the
research focus of many large companies has shifted toward the discovery
of new chemicals-providing the skill set necessary for upstream
outsourcing.
Bangalore is fast becoming one of major hubs of the biotechnology
industry in India. With Bangalore firmly established as the country'spremier IT and biotech hub, it comes as no surprise that the city is home to
India's largest biocluster. Approximately 158 of the 320 biotech
companies are based there, with total revenues of Rs 1,400 crore. Further,
An Overview of the Life Sciences
and Outsourcing Landscape in India:
Spotlight on Bangalore
-
8/22/2019 ISBTOC
3/5
3
fifty-five per cent of India's biotechnology companies are located in
Karnataka. The Government of Karnataka is committed to establishing abiotechnology corridor for the development of the biotechnology industry
in Karnataka.
Contract Research Organizations have great potential to function as exportoriented units and are comparable in their activity to the software
development activities in the IT sector. Software services were outsourced
by large overseas IT companies, starting initially with the sub-contractingsoftware development of small modules of complex software and a decade
later, the Indian IT sector is now capable of handling the entire software
development process-the primary reason for the prolific growth in the ITsector. Contract research in biotechnology offers the same growth
potential and the Government of Karnataka is firmly committed to
supporting these organizations.
Through the use of brief case studies we provide an overview of theactivities of several multinational companies located in Bangalore as wellas the current state of affair of contract research outsourcing in Bangalore.
Contact information is provided for these companies including key
executive names.
-
8/22/2019 ISBTOC
4/5
4
Executive Summary
The Drug Discovery and DevelopmentLife Cycle
The Innovation ProcessThe Drive toward Outsourcing
Contract Research
Early Drug DiscoveryContract Manufacturing
Regulation
Outsourcing Opportunities in India
The Life Sciences Industry in India
Trends across the Life CycleAdvantages of Outsourcing to India
Enabling Life Sciences and
Outsourcing in Bangalore
Government Policy
Infrastructure Development
Academic Support
Limitations to Overcome
Intellectual Property
RegulationLanguage and Culture
Business Models Operating in India
Focus on Drug Discovery
Preclinical Research and Business
ModelsFocus on Clinical Research
Clinical Research Business Models
Managing the Outsourcing
RelationshipSelection Process
Development of the Partnership
Case Studies: Biotechnology and
Pharmaceutical Companies in
Bangalore
Advinus TherapeuticsAstraZeneca India
Aurigene Discovery Technologies Ltd.Bangalore Genei Pvt. Ltd.
CytoGenomics Pvt. Ltd.
GlaxoSmithKline Pharmaceuticals Ltd.Jubilant BiosysMetahelix Life Sciences Pvt. Ltd.
Molecular Connections
Pharmed MedicareSartorius
Siri Technologies Pvt. Ltd.Strand Life SciencesStrides ArcolabTriesta SciencesXCyton DiagnosticXP Biotek Pvt. Ltd.
Case Studies: Contract Research
Organizations in Bangalore
Biocon India GroupSyngene
ClinigeneClinTec InternationalManipal AcunovaQuintiles IndiaRallis R&D CenterReaMetrix India Pvt. Ltd.Sanmar Specialty Chemicals LimitedSynchron Research Services Pvt. Ltd.
Table of Contents
-
8/22/2019 ISBTOC
5/5
5
List of Figures:
Outsourced Segments and Activities of the R&D Value Chain Biotechnology Performance across Asia-Pacific, Europe, and the United States Trends across the Indian R&D Value Chain Business Models Operating across the Early Discovery and Clinical Value Chain
List of Tables:
R&D Budget Break-Down Indias Current and Projected Share of the Preclinical and Clinical Services
Markets
Finding Preclinical and Clinical Service Providers Companies in Bangalore-Drug Discovery and Development Focus Contract Research Organizations in Bangalore-Services Offered